WISDOMTREE TR - US HGH YLD CORP (QHY) Institutional Ownership

CUSIP: 97717X172

13F Institutional Holders and Ownership History from Q2 2016 to Q4 2025

Type / Class
Equity / US HGH YLD CORP
Symbol
QHY
Price per share
$46.42
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,663,656
Total reported value
$170,143,560
% of total 13F portfolios
0%
Share change
+48,596
Value change
+$2,248,462
Number of holders
73
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 97717X172?
CUSIP 97717X172 identifies QHY - WISDOMTREE TR - US HGH YLD CORP in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 73 institutional investors reported holding 3,663,656 shares of WISDOMTREE TR - US HGH YLD CORP (QHY).

Institutional Holders of WISDOMTREE TR - US HGH YLD CORP (QHY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,663,656 $170,143,560 +$2,248,462 $46.44 73
2025 Q3 3,607,398 $167,970,741 +$4,245,410 $46.55 63
2025 Q2 3,517,183 $162,152,116 -$11,564,349 $46.10 66
2025 Q1 3,769,744 $169,964,426 -$2,721,145 $45.10 67
2024 Q4 3,829,905 $172,874,733 -$8,019,997 $45.14 60
2024 Q3 3,904,329 $180,341,858 -$7,103,613 $46.19 55
2024 Q2 4,017,710 $179,185,717 -$4,397,098 $44.60 52
2024 Q1 4,134,693 $187,317,692 -$9,100,728 $45.31 55
2023 Q4 4,335,291 $196,888,583 -$7,014,078 $45.42 59
2023 Q3 4,247,195 $183,463,330 +$14,527,367 $43.19 53
2023 Q2 4,020,620 $177,637,723 +$8,224,049 $44.15 48
2023 Q1 3,836,428 $171,663,871 +$38,497,368 $44.74 50
2022 Q4 2,861,545 $1,623,194,522 +$16,487,404 $43.93 45
2022 Q3 2,447,388 $104,655,000 -$28,263,745 $42.66 40
2022 Q2 3,102,026 $136,821,572 +$13,526,675 $44.00 43
2022 Q1 2,711,162 $133,694,889 +$19,290,044 $49.33 43
2021 Q4 2,503,772 $131,334,547 -$10,784,197 $52.47 43
2021 Q3 2,032,811 $106,980,683 +$23,374,946 $52.63 38
2021 Q2 2,159,739 $113,971,801 +$5,113,121 $52.77 36
2021 Q1 2,143,871 $111,737,152 -$18,351,633 $52.01 42
2020 Q4 2,411,468 $126,735,523 +$24,158,691 $52.50 33
2020 Q3 1,934,152 $98,391,736 +$4,099,736 $50.07 26
2020 Q2 1,829,767 $91,403,635 +$33,701,691 $48.68 25
2020 Q1 1,144,687 $55,749,365 +$1,609,790 $44.69 18
2019 Q4 1,090,518 $57,207,662 +$6,849,169 $52.09 18
2019 Q3 908,192 $47,508,217 +$13,365,444 $51.55 15
2019 Q2 649,235 $34,143,000 -$31,706 $51.35 9
2019 Q1 649,838 $34,136,000 -$961,962 $50.83 8
2018 Q4 97,889 $4,653,000 +$2,969,127 $47.53 7
2018 Q3 35,436 $1,789,000 -$530,673 $50.52 4
2018 Q2 45,950 $2,251,000 -$554,454 $49.01 4
2018 Q1 57,271 $2,828,000 -$1,024,446 $49.38 4
2017 Q4 77,997 $3,928,000 -$327,818 $50.30 4
2017 Q3 84,508 $4,324,000 -$500,373 $51.17 4
2017 Q2 94,287 $4,807,000 +$48,885 $50.97 4
2017 Q1 93,321 $4,741,000 +$57,456 $50.80 3
2016 Q4 92,190 $4,684,000 -$15,314 $50.79 3
2016 Q3 92,506 $4,732,000 -$170,741 $51.16 3
2016 Q2 96,326 $4,831,000 +$4,831,000 $50.16 2